Back to RecallTracker
Health Canada Health products

Importation of Fresenius Propoven 2% due to Shortage of Canadian Labelled Propofol Injection 1% Products

Issued May 19, 2020
Issue
Increased demand for propofol injection due to the COVID-19 pandemic has led to reported shortages and limited supply of this product in Canada. Given the medical necessity of propofol injection and increased demand to manage critically ill patients needing ventilation support, Health Canada has added Propoven 2% (propofol 20 mg/mL), 100 mL Emulsion for injection or infusion to the List of Drugs for Exceptional Importation and Sale , as an interim measure to help mitigate the shortage.
Hazard description
Product safety